Government Focussed On Maintaining A Strong Presence In The Global Pharmaceutical Industry.

BMI View: While the local pharmaceutical industry does not employee a large proportion of the UK labour force, the closure of sites by multinational drugmakers during the economic slowdown will put renewed pressure on government officials and life science specialists hoping to minimise the impact on jobs and expertise. The government's focus on drug approvals, innovation, clinical trials and tax measures highlights the government's recognition of the importance of creating a business environment attractive to drugmakers, reflecting its intention to maintain a strong presence in the global pharmaceutical industry.

To read the full article, please choose one of the following options: